‘Too costly, not enough evidence it works’, says UK in blow to cannabis campaigners
Cannabis Law Report
AUGUST 21, 2019
The draft NICE guideline also does not recommend the use of cannabis-based medicinal products for people with chronic pain, including people with MS experiencing nerve pain. The calculations used to reach this decision indicated that Sativex would be cost effective if the list price was reduced from £375 to £188 per pack.
Let's personalize your content